Genentech Executive Vice President Richard Scheller articulates his thought process in deciding to leave a tenured faculty position to join a commercial enterprise. While leaving Stanford was hard to do, says Scheller, joining Genentech provided new intellectual challenges and opportunities to apply his biological insights to tackling diseases.

Video clips from: Developing Products that Save Lives [Entire Talk]

5 minutes

Ethical Issues in Drug Development

Watch now

5 minutes

Motivating a Biotechnology Workforce

Watch now

4 minutes

Startup Opportunities in Biotechnology

Watch now

3 minutes

Encouraging Innovation and Risk Taking

Watch now

4 minutes

Pharmaceutical Market Realities

Watch now

6 minutes

Drug Development Process

Watch now

4 minutes

Choose Your Words Carefully

Watch now

6 minutes

Moving From Academia to Industry

Watch now

Share Post